[The effect of combinations of antibacterial preparations on resistant strains of pyelonephritis agents].
D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D002701:Chloramphenicol / Q000494:pharmacology; D004359:Drug Therapy, Combination; D004917:Erythromycin / Q000494:pharmacology; D004926:Escherichia coli / Q000187:drug effects; D004927:Escherichia coli Infections / Q000188:drug therapy; D009582:Nitrofurantoin / Q000494:pharmacology; D009827:Oleandomycin / Q000008:administration & dosage; D010403:Penicillin Resistance; D010406:Penicillins / Q000494:pharmacology; D011511:Proteus / Q000187:drug effects; D011512:Proteus Infections / Q000188:drug therapy; D011549:Pseudomonas / Q000187:drug effects; D011552:Pseudomonas Infections / Q000188:drug therapy; D011704:Pyelonephritis / Q000188:drug therapy* / Q000382:microbiology; D013203:Staphylococcal Infections / Q000188:drug therapy; D013210:Staphylococcus / Q000187:drug effects; D013290:Streptococcal Infections / Q000188:drug therapy; D013291:Streptococcus / Q000187:drug effects; D013752:Tetracycline / Q000008:administration & dosage / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D010406:Penicillins; D004917:Erythromycin; D002701:Chloramphenicol; D009582:Nitrofurantoin; D013752:Tetracycline; D009827:Oleandomycin
Deĭstvie sochetaniĭ antibakterial'nykh preparatov na rezistentnye shtammy vozbuditeleĭ pielonefrita